Skip to content Skip to footer

Canadian cannabis retailers reach new records in May as illicit market sales fall

Canadian cannabis retailers reach new records in May as illicit market sales fall
Share this story
Share on twitter
Share on linkedin
Share on email

July 24th, 2020

Arnau Valdovinos


 

A total of CAD$850 million worth of cannabis has now been sold in licensed dispensaries in the first 5 months of 2020, which means that, according to current projections, total sales are set to surpass the CAD$2 billion in 2020.

Since cannabis was legalised in Canada in October 2018, the contribution of legal cannabis to the country’s GDP (which takes into account domestic retail sales, investments, inventories and the balance of trade) has increased four-fold and currently represents 0.26% of Canada’s GDP, valued at CAD$4.3 billion.

This has come at the expense of illegal trade, which has been included in GDP estimates since 2017 to account for the effects of legalisation. The illicit market has plummeted 25% in the first 20 months of legalisation, slashing the policing and healthcare costs of prohibition, while hundreds of millions of dollars are being collected in excise duties, sales taxes and license fees.

At a provincial level, Alberta led the sales of legal cannabis in May 2020, with a quarter of all sales being produced in the Western province, despite it representing less than 12% of the Canadian population. This is mainly due to the liberal approach to cannabis retail implemented in the province, which is home to 497 dispensaries, despite some signs of overbuilding that has led to cost restructuring.

On the other hand, the largest province Ontario, home to 38% of the Canadian population, only accounted for 22% of sales in the last month of the period, following the slow approval process of new retail outlets. Ontario only counts with a 100 open storefronts, despite hundreds of pending applications.

Meanwhile, Quebec, where its public monopoly only possesses some 40 cannabis storefronts, represented 21% of sales. British Columbia accounted for 15% of sales in May 2020 while Saskatchewan accounted for 6% with the 8 other provinces and territories combined representing 11% of retail sales.

For more in-depth information, consumer data and strategic support, contact the Prohibition Partners consultancy team at info@prohibitionpartners.com or download one of our industry-leading reports.

Recent posts
May 19, 2022
Who Are Europe’s Medical Cannabis Patients?
May 5, 2022
Europe’s Pilot Trials Are a Tentative Step Towards Legal Medical Cannabis
April 28, 2022
The First Sales of Legal Adult-Use Cannabis in Europe Are Due in 2022
April 14, 2022
One Step Forward for CBD in the UK, but Questions Remain at Home and Abroad

Catch up on our newest articles that you might have missed

Untitled design (11)
May 19, 2022
Who Are Europe’s Medical Cannabis Patients?
The relatively close integration of medical cannabis into the European healthcare systems has contributed to a patient population and purchasing...
il-vagabiondo-Q7QCj-9-q3I-unsplash
May 5, 2022
Europe’s Pilot Trials Are a Tentative Step Towards Legal Medical Cannabis
Underlining the cautious approach Europe is taking to the liberalisation of medical cannabis are the pilot trial access schemes for...
vincent-ghilione-z54zUmYA9f8-unsplash
April 28, 2022
The First Sales of Legal Adult-Use Cannabis in Europe Are Due in 2022
Last week the first pilot project trial for the legalised sales of adult-use cannabis in Basel, Switzerland was approved by...
thomas-kelley--8iE9ykf3Us-unsplash
April 14, 2022
One Step Forward for CBD in the UK, but Questions Remain at Home and Abroad
The recent publishing of the list of CBD products with a valid Novel Foods application by the UK’s Food Safety...